Evidence map›Paper›PMID 36711279›Full record

ArticleHeliyon2023

Susceptibility to malaria in fulani, Bariba, Otamari and gando individuals living in sympatry in Benin: Role of opsonizing antibodies to Plasmodium falciparum merozoites.

Abdou Khadre Dit Jadir Fall, Ikhlaq Hussain Kana, Asier Garcia-Senosiain, Benoît Henry, Célia Dechavanne, André Garcia, Pierre Buffet, Audrey Sabbagh, Florence Migot-Nabias, Michael Theisen and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Abdou Khadre Dit Jadir FallUniversité Paris Cité, IRD, UMR261, MERIT, F-75006 Paris, France.
Ikhlaq Hussain KanaDepartment for Congenital Disorders, Statens Serum Institut, Denmark.
Asier Garcia-SenosiainDepartment for Congenital Disorders, Statens Serum Institut, Denmark.
Benoît HenryUniversité Paris Cité, Biologie Intégrée du Globule Rouge, UMR_S1134, BIGR, INSERM, Paris, France.
Célia DechavanneUniversité Paris Cité, IRD, UMR261, MERIT, F-75006 Paris, France.
André GarciaUniversité Paris Cité, IRD, UMR261, MERIT, F-75006 Paris, France.
Pierre BuffetUniversité Paris Cité, Biologie Intégrée du Globule Rouge, UMR_S1134, BIGR, INSERM, Paris, France.
Audrey SabbaghUniversité Paris Cité, IRD, UMR261, MERIT, F-75006 Paris, France.
Florence Migot-NabiasUniversité Paris Cité, IRD, UMR261, MERIT, F-75006 Paris, France.
Michael TheisenDepartment for Congenital Disorders, Statens Serum Institut, Denmark.
David CourtinUniversité Paris Cité, IRD, UMR261, MERIT, F-75006 Paris, France.
Université Paris Cité · FRStatens Serum Institut · DKInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Fulani in Africa are known to be less susceptible to Methods: Before the start of the malaria transmission season (MTS) in Benin, the functionality of antibodies against Results: In Bariba, Otamari and Gando, but not in Fulani, plasma from adults promoted higher levels of OP than the children (P = 0.003; P = 0.012; P = 0.031 and P = 0.122). A high proportion of Fulani children had higher OP and Conclusion: Our results highlight the ability of opsonizing antibodies to potentially enhance natural protection of young Fulani individuals against Pf malaria in Benin.

Indexed as

BeninFulaniMalaria resistanceOpsonic phagocytosis

Identifiers

PMID36711279
PMCPMC9879790
OpenAlexW4318542299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.